Ablative subthalamic nucleus surgery in Parkinson's disease. Necessary considerations
Keywords:
Key words, ablative subthalamic nucleus surgery, surgical treatment of Parkinson's disease.Abstract
According to the World Health Organization, in 2016 Parkinson's disease affected one person per every 100 people elder 60 years, meaning 6.3 millions of people, and by 2030 it will be around 12 million persons across the world. This neurodegenerative disorder, characterized by the nigro-striatal degradation and potentiation of the indirect route of the basal ganglia motor circuit, added to the accumulation of Lewy bodies in several structures of the Central Nervous System, progressively and inevitably affects the life quality of patients. The ablative procedures of the subthalamic nucleus are an alternative that propitiates proven effect and safety in the control of this disease symptoms. Therefore, the authors decided to describe the subthalamic nucleus ablation as a treatment for advanced Parkinson's disease.
Downloads
Download data is not yet available.
References
1. Hurwitz B. Urban observation and sentiment in James Parkinson's Essay on the Shaking Palsy (1817). Lit Med 2014 Spring;32(1):74-104. Citado en PubMed; PMID: 25055707.
2.Arredondo-Blanco K, Zerón-Martínez R, Rodríguez-Violante M,et al. Breve recorrido histórico de la enfermedad de Parkinson a 200 años de su descripción. Gac Med Mex [Internet]. 2018[citado 01/12/2019];154(6):719-726.Disponible en:https://pmlegacy.ncbi.nlm.nih.gov/pubmed/?term=Breve+recorrido+hist%C3%B3rico+de+la+enfermedad+de+Parkinson+a+200+a%C3%B1os+de+su+descripci%C3%B3n
3.Hasegawa M, Nonaka T, Masuda-Suzukake M. Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders. Pharmacol Ther. 2017 ;172:22-33.Citado en PubMed: PMID: 27916654.
4.Parkinson y yo, Organización Mundial de la Salud (OMS) . Parkinson y yo, Acerca del Parkinson [Internet]. Buenos Aires, Argentina: OMS [ citado 01/12/2019];2018 . Disponible en: http://terapiaparkinson.com/testimonial-view/organizacion-mundialde-la-salud-oms/
5.OPS. Trastornos neurológicos: un serio desafío para la salud pública en las Américas y en todo el mundo[Internet]. Estados Unidos: Organización Panamericana de la Salud [citado el 01/12/2019];2018. Disponible en: http://www.paho.org/hq/index.php?option=com_content&view=article&id=240%3A2008-trastornos-neurologicos-un-seriodesafio-salud-publica-americas-todo-mundo&catid=916%3Ariskfactors&Itemid=40595&lang=es
6.Condor I, Atencio-Paulino J, Contreras-Cordova CR. Características clínico epidemiológicas de la Enfermedad de Parkinson en un Hospital nacional de la Sierra Peruana. Rev Fac Med Hum [Internet]. 2019 [citado el 01/12/2019];19(4):14-21.Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2308-05312019000400004
7.Benito-Leon J. Epidemiologia de la enfermedad de Parkinson en España y su contextualizacion mundial. Rev Neurol. 2018;66(4):125-134.Citado en PubMed; PMID: 29435969.
8.Ricardo Y, Pavon N, Alvarez L, et al. Long-term effect of unilateral subthalamotomy for Parkinson's disease. J Neurol Neurosurg Psychiatry. 2019 Dec;90(12):1380-1381.Citado en PubMed: PMID: 31085584.
9.Galvan A, Smith Y. Anatomy and Synaptic Connectivity of the Basal Ganglia. In: Winn HR. Yumans and Winn Neurological Surgery[Internet]. 7ma Ed. Philadelphia: ELSEVIER. [citado el 01/12/2019]; 2017.p. 521-539.Disponible en: https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
10.Jellinger KA. Neuropathology of Movement Disorders. In: Winn HR. Yumans and Winn Neurological Surgery[Internet]. 7ma Ed. Philadelphia: ELSEVIER[citado el 01/12/2019]; 2017.p. 540-80. Disponible en : https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
11.Martínez-Fernández R, Gasca-Salas C, Sánchez-Ferro A Actualización en la Enfermedad de ParkinsonRev Med Clin Condes[Internet]. [Citado en 10/03/2019]; 27(3): 363-79.Disponible en:https://www.sciencedirect.com/science/article/pii/S0716864016300372
12.Méndez-Herrera C. El núcleo subtalámico en la fisiopatología de la enfermedad de Parkinson y su rol como diana quirúrgica. Rev Chil Neuro-Psiquiatr [Internet]. [Citado 12/11/ 2011];49(1).Disponible en:https://scielo.conicyt.cl/scielo.php?script=sci_abstract&pid=S0717-92272011000100008&lng=es&nrm=iso
13.Salva Camaño SN. Historia de la estereotaxia, la braquiterapia y la radiocirugía en Cuba. Rev Méd Electrón [Internet]. [citado en 12/10/2019]; 33(7). Disponible en:
http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/904/pdf
14.Wichmann, DeLong MR. Rationale for Surgical Interventions in Movement Disorders. In: Winn HR. Yumans and Winn Neurological Surgery. 7ma Ed. Philadelphia: ELSEVIER [Internet];2017. p. 565-570. https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
15.Cho C, Isaias IU, Tagliati M. Patient Selection Criteria for Deep Brain Stimulation in Movement Disorders. In: Winn HR. Yumans and Winn Neurological Surgery. 7ma Ed. Philadelphia: ELSEVIER [Internet]. [citado en 12/10/2019]; 2017. p. 586-595. Disponible en : https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
16.Schuepbach WM, Rau J, Knudsen K,et al. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med. 2013 Feb 14;368(7):610-22. Citado en PubMed ;PMID: 23406026.
17.Deuschl G, Follett KA, Luo P, et al. Comparing two randomized deep brain stimulation trials for Parkinson's disease. J Neurosurg. 2019 Apr 5:1-9.Citado en PubMed; PMID: 30952118.
18.Hariz M, Blomstedt P. Surgical Management of Tremor. In: Winn HR. Yumans and Winn Neurological Surgery[Internet]. 7ma Ed. Philadelphia: ELSEVIER [citado en 12/10/2019]; 2017. p. 596-601. Disponible en : https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
19.Gross RE, Stern MA, Lazarus JT. Ablative Procedures for Parkinson’s Disease. In: Winn HR. Yumans and Winn Neurological Surgery[Internet]. 7ma Ed. Philadelphia: ELSEVIER [citado en 12/10/2019]; 2017. p. 610-618. Disponible en : https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
20.Odekerken VJ, Boel JA, Schmand BA, et al. NSTAPS study group. GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up. Neurology. 2016 Feb 23;86(8):755-61. Citado en PubMed; PMID: 26819458.
21.Panov FE, Larson P, Martin A . Deep Brain Stimulation for Parkinson’s Disease[Internet]. In: Winn HR. Yumans and Winn Neurological Surgery. 7ma Ed. Philadelphia: ELSEVIER [citado en 12/10/2019]; 2017. p. 531-545. Disponible en : https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
22.Johnson LA, Vitek JL. Deep Brain Stimulation: Mechanismis of Action[Internet]. In: Winn HR. Yumans and Winn Neurological Surgery. 7ma Ed. Philadelphia: ELSEVIER [citado en 12/10/2019];2017. p. 635-646. Disponible en : https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
23.Rapoport BI, Kaplitt MG. Emerging and Experimental Neurosurgical Treatments for Parkinson’s Disease[Internet]. In: Winn HR. Yumans and Winn Neurological Surgery. 7ma Ed. Philadelphia: ELSEVIER. [citado en 12/10/2019]; 2017. p. 660-664. Disponible en : https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
24.Taira T, Nakajima T, Ochiai T, et al. Thalamotomy for Focal Hand Dystonia. In: Winn HR. Yumans and Winn Neurological Surgery[Internet]. 7ma Ed. Philadelphia: ELSEVIER[citado en 12/10/2019]; 2017. p. 678-683. Disponible en : https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
25.Lipsman N, Schwartz ML, Huang Y, et al. MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study. Lancet Neurol. 2013 May;12(5):462-8. Citado en PubMed; PMID: 23523144.
26.Schlesinger I, Eran A, Sinai A, et al. MRI Guided Focused Ultrasound Thalamotomy for Moderate-to-Severe Tremor in Parkinson's Disease. Parkinsons Dis. 2015;2015:219149. Citado en PubMed; PMID: 26421209.
2.Arredondo-Blanco K, Zerón-Martínez R, Rodríguez-Violante M,et al. Breve recorrido histórico de la enfermedad de Parkinson a 200 años de su descripción. Gac Med Mex [Internet]. 2018[citado 01/12/2019];154(6):719-726.Disponible en:https://pmlegacy.ncbi.nlm.nih.gov/pubmed/?term=Breve+recorrido+hist%C3%B3rico+de+la+enfermedad+de+Parkinson+a+200+a%C3%B1os+de+su+descripci%C3%B3n
3.Hasegawa M, Nonaka T, Masuda-Suzukake M. Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders. Pharmacol Ther. 2017 ;172:22-33.Citado en PubMed: PMID: 27916654.
4.Parkinson y yo, Organización Mundial de la Salud (OMS) . Parkinson y yo, Acerca del Parkinson [Internet]. Buenos Aires, Argentina: OMS [ citado 01/12/2019];2018 . Disponible en: http://terapiaparkinson.com/testimonial-view/organizacion-mundialde-la-salud-oms/
5.OPS. Trastornos neurológicos: un serio desafío para la salud pública en las Américas y en todo el mundo[Internet]. Estados Unidos: Organización Panamericana de la Salud [citado el 01/12/2019];2018. Disponible en: http://www.paho.org/hq/index.php?option=com_content&view=article&id=240%3A2008-trastornos-neurologicos-un-seriodesafio-salud-publica-americas-todo-mundo&catid=916%3Ariskfactors&Itemid=40595&lang=es
6.Condor I, Atencio-Paulino J, Contreras-Cordova CR. Características clínico epidemiológicas de la Enfermedad de Parkinson en un Hospital nacional de la Sierra Peruana. Rev Fac Med Hum [Internet]. 2019 [citado el 01/12/2019];19(4):14-21.Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2308-05312019000400004
7.Benito-Leon J. Epidemiologia de la enfermedad de Parkinson en España y su contextualizacion mundial. Rev Neurol. 2018;66(4):125-134.Citado en PubMed; PMID: 29435969.
8.Ricardo Y, Pavon N, Alvarez L, et al. Long-term effect of unilateral subthalamotomy for Parkinson's disease. J Neurol Neurosurg Psychiatry. 2019 Dec;90(12):1380-1381.Citado en PubMed: PMID: 31085584.
9.Galvan A, Smith Y. Anatomy and Synaptic Connectivity of the Basal Ganglia. In: Winn HR. Yumans and Winn Neurological Surgery[Internet]. 7ma Ed. Philadelphia: ELSEVIER. [citado el 01/12/2019]; 2017.p. 521-539.Disponible en: https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
10.Jellinger KA. Neuropathology of Movement Disorders. In: Winn HR. Yumans and Winn Neurological Surgery[Internet]. 7ma Ed. Philadelphia: ELSEVIER[citado el 01/12/2019]; 2017.p. 540-80. Disponible en : https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
11.Martínez-Fernández R, Gasca-Salas C, Sánchez-Ferro A Actualización en la Enfermedad de ParkinsonRev Med Clin Condes[Internet]. [Citado en 10/03/2019]; 27(3): 363-79.Disponible en:https://www.sciencedirect.com/science/article/pii/S0716864016300372
12.Méndez-Herrera C. El núcleo subtalámico en la fisiopatología de la enfermedad de Parkinson y su rol como diana quirúrgica. Rev Chil Neuro-Psiquiatr [Internet]. [Citado 12/11/ 2011];49(1).Disponible en:https://scielo.conicyt.cl/scielo.php?script=sci_abstract&pid=S0717-92272011000100008&lng=es&nrm=iso
13.Salva Camaño SN. Historia de la estereotaxia, la braquiterapia y la radiocirugía en Cuba. Rev Méd Electrón [Internet]. [citado en 12/10/2019]; 33(7). Disponible en:
http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/904/pdf
14.Wichmann, DeLong MR. Rationale for Surgical Interventions in Movement Disorders. In: Winn HR. Yumans and Winn Neurological Surgery. 7ma Ed. Philadelphia: ELSEVIER [Internet];2017. p. 565-570. https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
15.Cho C, Isaias IU, Tagliati M. Patient Selection Criteria for Deep Brain Stimulation in Movement Disorders. In: Winn HR. Yumans and Winn Neurological Surgery. 7ma Ed. Philadelphia: ELSEVIER [Internet]. [citado en 12/10/2019]; 2017. p. 586-595. Disponible en : https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
16.Schuepbach WM, Rau J, Knudsen K,et al. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med. 2013 Feb 14;368(7):610-22. Citado en PubMed ;PMID: 23406026.
17.Deuschl G, Follett KA, Luo P, et al. Comparing two randomized deep brain stimulation trials for Parkinson's disease. J Neurosurg. 2019 Apr 5:1-9.Citado en PubMed; PMID: 30952118.
18.Hariz M, Blomstedt P. Surgical Management of Tremor. In: Winn HR. Yumans and Winn Neurological Surgery[Internet]. 7ma Ed. Philadelphia: ELSEVIER [citado en 12/10/2019]; 2017. p. 596-601. Disponible en : https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
19.Gross RE, Stern MA, Lazarus JT. Ablative Procedures for Parkinson’s Disease. In: Winn HR. Yumans and Winn Neurological Surgery[Internet]. 7ma Ed. Philadelphia: ELSEVIER [citado en 12/10/2019]; 2017. p. 610-618. Disponible en : https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
20.Odekerken VJ, Boel JA, Schmand BA, et al. NSTAPS study group. GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up. Neurology. 2016 Feb 23;86(8):755-61. Citado en PubMed; PMID: 26819458.
21.Panov FE, Larson P, Martin A . Deep Brain Stimulation for Parkinson’s Disease[Internet]. In: Winn HR. Yumans and Winn Neurological Surgery. 7ma Ed. Philadelphia: ELSEVIER [citado en 12/10/2019]; 2017. p. 531-545. Disponible en : https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
22.Johnson LA, Vitek JL. Deep Brain Stimulation: Mechanismis of Action[Internet]. In: Winn HR. Yumans and Winn Neurological Surgery. 7ma Ed. Philadelphia: ELSEVIER [citado en 12/10/2019];2017. p. 635-646. Disponible en : https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
23.Rapoport BI, Kaplitt MG. Emerging and Experimental Neurosurgical Treatments for Parkinson’s Disease[Internet]. In: Winn HR. Yumans and Winn Neurological Surgery. 7ma Ed. Philadelphia: ELSEVIER. [citado en 12/10/2019]; 2017. p. 660-664. Disponible en : https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
24.Taira T, Nakajima T, Ochiai T, et al. Thalamotomy for Focal Hand Dystonia. In: Winn HR. Yumans and Winn Neurological Surgery[Internet]. 7ma Ed. Philadelphia: ELSEVIER[citado en 12/10/2019]; 2017. p. 678-683. Disponible en : https://www.elsevier.com/books/youmans-and-winn-neurological-surgery-4-volume-set/winn/978-0-323-28782-1
25.Lipsman N, Schwartz ML, Huang Y, et al. MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study. Lancet Neurol. 2013 May;12(5):462-8. Citado en PubMed; PMID: 23523144.
26.Schlesinger I, Eran A, Sinai A, et al. MRI Guided Focused Ultrasound Thalamotomy for Moderate-to-Severe Tremor in Parkinson's Disease. Parkinsons Dis. 2015;2015:219149. Citado en PubMed; PMID: 26421209.
Published
2020-03-12
How to Cite
1.
Sierra Benitez EM, León Pérez MQ, Solomón Cardona MT. Ablative subthalamic nucleus surgery in Parkinson’s disease. Necessary considerations. Rev Méd Electrón [Internet]. 2020 Mar. 12 [cited 2025 Apr. 20];42(6):1-15. Available from: https://revmedicaelectronica.sld.cu/index.php/rme/article/view/3631
Issue
Section
Review article
License
All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.
It allows:
- Copy and redistribute published material in any medium or format.
- Adapt the content.
This will be done under the following terms:
- Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.
- Non-commercial use.
- Recognize the journal where it is published.
The copyrights of each article are maintained, without restrictions.
Guidelines to authors
